Mahima Datla is Managing Director of Biological E Limited, where she oversees strategic operations within the organisation and leads on work related to public policy. She has held the tenure with Biological E for the past 17 years and has served in various capacities across a diverse range of functions, including Biotechnology & Projects, Operations and Strategic Business Development. Under Ms Datla’s leadership, Biological E has demonstrated growth, given the successful WHO pre-qualification and launch of the Pentavalent and JE vaccines.
Apart from Biological E, Ms Datla has served on the steering committee of DCVMN (Developing Countries Vaccine Manufacturers Network) and is currently its President. She is a member of FICCI (Federation of Indian Chambers of Commerce and Industry) and CII (Confederation of Indian Industry) National Biotech committees in India. She is currently a board member of the Global Health Innovative Technology fund, a Japanese government innovation healthcare fund for improving global access to healthcare; and a member of the Board of Directors of the Sadhikaratha Foundation. She is also a member of the Life Sciences Advisory Committee formed by the Government of Telangana, India. Ms Datla was previously on the Gavi Alliance Board from 2011 to 2014.
She holds a graduate degree in Business Administration Management from Webster University, London (UK).